CIPH Ciphergen Biosystems (MM)

Ciphergen Biosystems, Inc. Announces Year End 2004 Financial Results and Events Webcast Details FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH), will announce Year End 2004 Financial Results and Events on Thursday, February 17, 2005, after market close, followed on Friday, February 18, 2005, by its Quarterly Conference Call at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Daylight Time). The call is being webcast by PR Newswire and can be accessed at Ciphergen's web site at http://www.ciphergen.com/ (Investor Relations Section). Additionally, a telephone replay of the teleconference will be available for 24 hours beginning at 10:00 a.m. (EST) on Friday, February 18, 2005 and can be accessed by dialing Domestic: 800-642-1687 or International: 706-645-9291 - Conference ID # 3829458 About Ciphergen: Ciphergen's Biosystems Division develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research, and process proteomics applications. ProteinChip Systems enable protein discovery, characterization, identification and assay development to provide researchers with predictive, multi-marker assay capabilities and a better understanding of biological function at the protein level. Ciphergen's Diagnostics Division is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Center(R) laboratories for biomarker discovery for new diagnostic tests as well as pharmacoproteomic services for improved drug toxicology, efficacy and theranostic assays. Additional information about Ciphergen can be found at http://www.ciphergen.com/. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers of Ciphergen Biosystems, Inc., +1-510-505-2233, or Web site: http://www.ciphergen.com/

Copyright